AmoxicillinClavulanicAcidQualityChecker

Amoxicillin Clavulanic Acid

antibiotics API assay biosimilars dissolution fixed-dose combinations generics impurities
Open selection

Amoxicillin Clavulanic Acid Quality Checker — Combined Antibiotic (Ph. Eur., USP)

ℹ️ The utility checks content of both APIs, amoxicillin polymer, clavulanate degradation products, moisture.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! Amoxicillin polymer ≤0.05% (allergy). Moisture ≤2.5% (clavulanate stability)!

Usage:
AmoxicillinClavulanicAcidQualityChecker.exe → demo mode
AmoxicillinClavulanicAcidQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,Amoxicillin_Content_Percent,Clavulanic_Acid_Content_Percent,Ratio_Amo_Clav,Amoxicillin_Polymer_Percent,Clavulanate_Degradation_Products_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Water_Content_KF_Percent,Dissolution_Amoxicillin_Percent,Dissolution_Clavulanate_Percent,Weight_Variation_RSD,Disintegration_Time_Min,Heavy_Metals_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected

Example:
AMX-CLV-2026-001,99.5,98.2,4.0,0.02,0.4,0.8,1.2,1.5,95.0,93.5,1.5,6.0,5,20,5,0,0

— WHY IS THIS NEEDED?
Combination of Amoxicillin (penicillin) + Clavulanic Acid (beta-lactamase inhibitor):
• Clavulanic acid is chemically unstable, degrades rapidly with moisture and heat
• Amoxicillin can form high molecular weight polymers (protein-antibiotic conjugates), which are potent allergens
• Strict ratio of components required for efficacy (typically 2:1, 4:1, 7:1)
• Moisture control critical for shelf life
⚠️ CRITICAL:
• Amoxicillin Content: 95–105%
• Clavulanic Acid Content: 90–110% (wider range allowed due to instability)
• Amoxicillin Polymer: ≤ 0.05% (strict! anaphylaxis risk)
• Clavulanate Degradation Products: ≤ 1.0%
• Moisture (LOD/KF): ≤ 2.0–2.5% (exceedance leads to rapid clavulanate decomposition during storage)
• Dissolution: ≥ 80% for both components
• Microbiology: absence of pathogens, limits for TAMC/TYMC
⚠️ Note: Utility places special emphasis on clavulanate stability. Exceeding moisture or clavulanic acid degradation products is a common cause of batch rejection for penicillins with inhibitors. Amoxicillin polymer check is mandatory for all penicillins due to cross-allergy risk.

input.csv

BatchNumber,Amoxicillin_Content_Percent,Clavulanic_Acid_Content_Percent,Ratio_Amo_Clav,Amoxicillin_Polymer_Percent,Clavulanate_Degradation_Products_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Water_Content_KF_Percent,Dissolution_Amoxicillin_Percent,Dissolution_Clavulanate_Percent,Weight_Variation_RSD,Disintegration_Time_Min,Heavy_Metals_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
AMX-CLV-2026-001,99.5,98.2,4.0,0.02,0.4,0.8,1.2,1.5,95.0,93.5,1.5,6.0,5,20,5,0,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: AmoxicillinClavulanicAcidQualityCheckerAPI / object: Amoxicillin Clavulanic AcidCategory: Global API

1. Scope

The Amoxicillin Clavulanic Acid Quality Checker utility is used for Amoxicillin Clavulanic Acid. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API

Tags: antibiotics, API, assay, biosimilars, dissolution, fixed-dose combinations, generics, impurities, market map, microbiology, water quality

2. Execution modes

AmoxicillinClavulanicAcidQualityChecker.exe                            → demo mode
AmoxicillinClavulanicAcidQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • dissolution / disintegration
  • microbiology and pathogens
  • heavy metals / elemental impurities

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! Amoxicillin polymer ≤0.05% (allergy). Moisture ≤2.5% (clavulanate stability)!
  • ⚠️ CRITICAL:
  • Amoxicillin Content: 95–105%
  • Clavulanic Acid Content: 90–110% (wider range allowed due to instability)
  • Amoxicillin Polymer: ≤ 0.05% (strict! anaphylaxis risk)
  • Clavulanate Degradation Products: ≤ 1.0%
  • Moisture (LOD/KF): ≤ 2.0–2.5% (exceedance leads to rapid clavulanate decomposition during storage)
  • Dissolution: ≥ 80% for both components
  • Microbiology: absence of pathogens, limits for TAMC/TYMC
  • ⚠️ Note: Utility places special emphasis on clavulanate stability. Exceeding moisture or clavulanic acid degradation products is a common cause of batch rejection for penicillins with inhibitors. Amoxicillin polymer check is mandatory for all penicillins due to cross-allergy risk.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Amoxicillin Clavulanic Acid with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, dissolution / disintegration, microbiology and pathogens, heavy metals / elemental impurities.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberAMX-CLV-2026-001mandatory field; used for batch/lot traceability
2Amoxicillin_Content_Percentdecimal%Amoxicillin Content %99.5numeric value; compared with assay/purity limit from specification or method
3Clavulanic_Acid_Content_Percentdecimal%Clavulanic Acid Content %98.2numeric value; compared with assay/purity limit from specification or method
4Ratio_Amo_Clavdecimalas specifiedRatio Amo Clav4.0mandatory numeric value; rule comparison is performed by the utility
5Amoxicillin_Polymer_Percentdecimal%Amoxicillin Polymer %0.02mandatory numeric value; rule comparison is performed by the utility
6Clavulanate_Degradation_Products_Percentdecimal%Clavulanate Degradation Products %0.4numeric value; compared with individual or total impurity limit
7Total_Impurities_Percentdecimal%Total Impurities %0.8mandatory numeric value; rule comparison is performed by the utility
8Loss_On_Drying_Percentdecimal%Loss On Drying %1.2mandatory numeric value; rule comparison is performed by the utility
9Water_Content_KF_Percentdecimal%Water Content KF %1.5numeric value; compared with assay/purity limit from specification or method
10Dissolution_Amoxicillin_Percentdecimal%Dissolution Amoxicillin %95.0numeric value; dissolution/disintegration profile checked according to method
11Dissolution_Clavulanate_Percentdecimal%Dissolution Clavulanate %93.5numeric value; dissolution/disintegration profile checked according to method
12Weight_Variation_RSDdecimalas specifiedWeight Variation RSD1.5mandatory numeric value; rule comparison is performed by the utility
13Disintegration_Time_MindecimalminDisintegration Time Min6.0numeric value; dissolution/disintegration profile checked according to method
14Heavy_Metals_ppmdecimalppmHeavy Metals ppm5numeric value; checked as elemental/metal impurity
15Microbial_Count_TAMCdecimalas specifiedMicrobial Count TAMC20numeric value; compared with microbiological limits
16Microbial_Count_TYMCdecimalas specifiedMicrobial Count TYMC5numeric value; compared with microbiological limits
17EColi_Detectedboolean / flag0/1EColi Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
18Salmonella_Detectedboolean / flag0/1Salmonella Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent

CSV example

BatchNumber,Amoxicillin_Content_Percent,Clavulanic_Acid_Content_Percent,Ratio_Amo_Clav,Amoxicillin_Polymer_Percent,Clavulanate_Degradation_Products_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Water_Content_KF_Percent,Dissolution_Amoxicillin_Percent,Dissolution_Clavulanate_Percent,Weight_Variation_RSD,Disintegration_Time_Min,Heavy_Metals_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
AMX-CLV-2026-001,99.5,98.2,4.0,0.02,0.4,0.8,1.2,1.5,95.0,93.5,1.5,6.0,5,20,5,0,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable AmoxicillinClavulanicAcidQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Amoxicillin Clavulanic Acid, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "AmoxicillinClavulanicAcidQualityChecker",
  "api": "Amoxicillin Clavulanic Acid",
  "batchNumber": "AMX-CLV-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "AMX-CLV-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Amoxicillin_Content_Percent",
      "value": "99.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Clavulanic_Acid_Content_Percent",
      "value": "98.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Ratio_Amo_Clav",
      "value": "4.0",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Amoxicillin_Polymer_Percent",
      "value": "0.02",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Clavulanate_Degradation_Products_Percent",
      "value": "0.4",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Total_Impurities_Percent",
      "value": "0.8",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Loss_On_Drying_Percent",
      "value": "1.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.
TC-006Insufficient dissolution or excessive disintegration timeFAIL/WARNING is produced according to method criticality.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Bangladesh: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Democratic Republic of the Congo: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Dental & Dental Materials QC Suite

QC utility package for dental medicinal products, oral-care products and dental materials: anaesthetics, antiseptics, analgesic/anti-infective products, polymers/minerals, resins, bonding workflows, microbiology, stability and material QC.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Ethiopia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Global API & Biosimilars QC Suite

Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.

Open

India: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Indonesia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Infectious Diseases QC Suite

QC utility package for infectious diseases: antibacterial, antiviral, antifungal and antiparasitic products, microbiology, sterility, endotoxins, viral safety and vaccine release checks.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Kenya: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Myanmar: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Nigeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Pakistan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Africa: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Sudan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Tanzania: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Uganda: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open